Adjuvant carboplatin added to standard anthracycline/taxane chemotherapy significantly improves outcomes in early triple-negative breast cancer, phase 3 data show.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/debate-over-data-support-adjuvant-carboplatin-early-tnbc-2025a100109q?src=rss
Author :
Publish date : 2025-12-24 09:51:00
Copyright for syndicated content belongs to the linked Source.